针叶类的树
发表于 2025-3-23 11:38:42
,In Vitro and In Vivo Models of Circulating Tumor Cells,ecent years. CTCs can function as potential real-time decision-making guides for selecting appropriate therapies during the course of the disease or for the development and testing of new treatments. However, these cells are extremely rare and require technology that is sensitive and specific enough
馆长
发表于 2025-3-23 16:25:57
http://reply.papertrans.cn/17/1644/164316/164316_12.png
Allure
发表于 2025-3-23 19:59:48
http://reply.papertrans.cn/17/1644/164316/164316_13.png
晚来的提名
发表于 2025-3-23 22:16:57
http://reply.papertrans.cn/17/1644/164316/164316_14.png
antiandrogen
发表于 2025-3-24 03:20:06
Circulating Tumor Cells in Colorectal Cancer,platin and irinotecan. At the beginning of the formation and growth of a primary tumor, the cells are eliminated from the primary tumor and then circulate through the bloodstream, called circulating tumor cells (CTCs). In CCR, CTCs can be used for screening, in localized and metastatic cancer, which is explicated in this chapter.
鞠躬
发表于 2025-3-24 06:44:56
http://reply.papertrans.cn/17/1644/164316/164316_16.png
Harbor
发表于 2025-3-24 11:56:08
Circulating Tumor Cells in Prostate Cancer,an classical imaging evaluation (RECIST) in prostate cancer. This chapter summarizes and discusses the clinical results obtained in prostate cancer and clinical trials and the biological findings about cancer biology and metastasis that were obtained from CTC of prostate cancer.
Neuropeptides
发表于 2025-3-24 18:30:31
http://reply.papertrans.cn/17/1644/164316/164316_18.png
LEVY
发表于 2025-3-24 19:27:13
https://doi.org/10.1007/978-3-319-00942-1h breast cancer, in addition to demonstrating and comparing the CellSearch system (approved by the Food and Drug Administration – FDA) and ISET® Technology – Rarecells (Isolation by SizE of Tumor Cells) used for the identification and cytopathological characterization of CTCs. Therefore, we can stat
训诫
发表于 2025-3-25 02:27:25
https://doi.org/10.1007/978-3-319-00942-1ently of antibodies. This chapter is a review of studies involving CTCs of head and neck cancer and exposes the potential impact of CTCs on the prognosis of patients, the main clinical trials, and methodologies involving the topic.